TRANSGENE
TRANSGENE operates in Diversified Metals & Mining.
Market Cap & Net Worth: TRANSGENE (TGNA)
TRANSGENE (BE:TGNA) has a market capitalization of $8.86K (€8.63K) as of March 18, 2026. Listed on the BE stock exchange, this Germany-based company holds position #45237 globally and #7468 in its home market, demonstrating a -2.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TRANSGENE's stock price €0.89 by its total outstanding shares 9715 (9.71K).
TRANSGENE Market Cap History: 2015 to 2025
TRANSGENE's market capitalization history from 2015 to 2025. Data shows change from $23.30K to $8.86K (-11.07% CAGR).
TRANSGENE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TRANSGENE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
TRANSGENE's market cap is 0.01 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $25.14K | $2.35 Million | -$25.21 Million | 0.01x | N/A |
| 2017 | $25.67K | $2.10 Million | -$32.27 Million | 0.01x | N/A |
| 2018 | $24.69K | $1.33 Million | $8.03 Million | 0.02x | 0.00x |
| 2019 | $14.94K | $6.65 Million | -$18.80 Million | 0.00x | N/A |
| 2020 | $16.23K | $2.98 Million | -$17.23 Million | 0.01x | N/A |
| 2021 | $24.48K | $9.99 Million | -$19.54 Million | 0.00x | N/A |
| 2022 | $16.02K | $3.13 Million | -$32.80 Million | 0.01x | N/A |
| 2023 | $13.24K | $1.18 Million | -$22.33 Million | 0.01x | N/A |
Competitor Companies of TGNA by Market Capitalization
Companies near TRANSGENE in the global market cap rankings as of March 18, 2026.
Key companies related to TRANSGENE by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
TRANSGENE Historical Marketcap From 2015 to 2025
Between 2015 and today, TRANSGENE's market cap moved from $23.30K to $ 8.86K, with a yearly change of -11.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €8.86K | +33.53% |
| 2024 | €6.63K | -49.92% |
| 2023 | €13.24K | -17.31% |
| 2022 | €16.02K | -34.58% |
| 2021 | €24.48K | +50.80% |
| 2020 | €16.23K | +8.68% |
| 2019 | €14.94K | -39.50% |
| 2018 | €24.69K | -3.80% |
| 2017 | €25.67K | +2.11% |
| 2016 | €25.14K | +7.90% |
| 2015 | €23.30K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of TRANSGENE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.86K USD |
| MoneyControl | $8.86K USD |
| MarketWatch | $8.86K USD |
| marketcap.company | $8.86K USD |
| Reuters | $8.86K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.